Andrea Necchi, MD

Articles by Andrea Necchi, MD

Andrea Necchi, MD, outlines why rare GU cancers demand faster diagnosis

ByAndrea Necchi, MD

March 13th 2026

On diagnostic pitfalls, Necchi highlights penile cancer as a particularly common source of delay.

Andrea Necchi, MD, highlights final results from the SunRISe-4 trial

ByAndrea Necchi, MD

November 25th 2025

The data, presented at ESMO, support a role for gemcitabine intravesical system plus cetrelimab in MIBC.

Andrea Necchi, MD, highlights data on neoadjuvant nivolumab plus visugromab in MIBC

ByAndrea Necchi, MD

Published: October 17th 2025 | Updated: October 17th 2025

Andrea Necchi, MD, shares key findings from the phase 2 GDFather-NEO trial, presented at ESMO 2025.

Perioperative outcomes support benefit of TAR-200 plus cetrelimab in MIBC

ByAndrea Necchi, MD,Hannah Clarke

March 26th 2025

"Provided that we will confirm the efficacy data long-term, there is an opportunity to spare, de-escalate a bit, the treatment in select patients, and to expose the patient with inferior risk of developing severe [adverse] effects," says Andrea Necchi, MD.